跳至主要内容
临床试验/ITMCTR2200005917
ITMCTR2200005917招募中4 期

Study on the effectiveness and safety of Tongluo Qutong Ointment in treating pain caused by nerve root type cervical spondylosis (blood stasis, cold and dampness blocking collateral syndrome)

Gansu Province second People's Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. It conforms to the western diagnostic criteria of cervical spondylotic radiculopathy;
  • 2. Neck and/or shoulder and back pain were the main clinical manifestations, and the VAS score of single site pain was =4;
  • 3. The medical history of cervical spondylosis was less than 5 years, and the onset of cervical spondylosis was less than 1 week;
  • 4. Aged 18-65, male or female;
  • 5. Junior high school education or above, with more than 1 year experience in using smart phones;
  • 6. Subject gives informed consent and signs relevant documents.

排除标准

  • 1. Patients with cervical spondylosis with cervical type, myeloid type, vertebral artery type and sympathetic type as the main symptoms; Always,
  • X-ray /CT/MRI examination showed that the history of cervical spondylosis > 5 years;
  • 2. Other disorders with upper extremity pain, such as neck sprain, thoracic outlet syndrome, tennis elbow, carpal tunnel
  • Syndrome, periarthritis of shoulder, rheumatic myofibrositis, biceps longhead tenosynovitis, etc.
  • 3.1 Patients who had received systematic treatment of cervical spondylosis within weeks, or were using analgesics, non-steroidal anti-inflammatory drugs,
  • Antidepressants or quinolones;
  • 4. Those who have received neck surgery; Cervical vertebra fracture, cervical vertebra congenital malformation, cervical canal osseous stenosis, nerve
  • Periroot inflammation; Complicated with tumor, tuberculosis and other diseases;
  • 5. Liver function (ALT/AST/TBil) exceeds 1.5 times the upper limit of normal value, and renal function Cr exceeds the upper limit of normal value;
  • 6. Have serious primary cardiovascular disease, liver disease, kidney disease, hematologic disease, lung disease or
  • Serious diseases affecting their survival;
  • 7. Patients with cervical spondylosis suitable for surgery (including: 1. Non-surgical treatment of more than 3 to 6 months by regular system is invalid or
  • Non-operative treatment is effective but recurrent and severe symptoms, affecting normal life or workers; 2. Progressive atrophy of the innervated muscles due to radiculopathy; 3. Patients with obvious symptoms of nerve root tingling, acute and severe pain, seriously affecting sleep and normal life), or those who plan to receive surgical treatment;
  • 8. Neck damage or abnormal skin (such as rash, eczema, etc.), allergic skin;
  • 9. Women who are breast-feeding, pregnant or planning pregnancy within six months;
  • 10. People who have a history of drug allergy, or allergic constitution (allergic to more than 2 kinds of substances). Always,
  • Asthma, urticaria or anaphylaxis after taking aspirin or other nsaids;
  • 11. Those who have participated in other clinical trials within 3 months after consultation;
  • 12. Those with conditions considered unsuitable for the study, such as a long history of alcohol consumption.

研究者

发起方
Gansu Province second People's Hospital

相似试验